Cargando…
The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ
Mammary MCF-10A cells seeded on reconstituted basement membrane form spherical structures with a hollow central lumen, termed acini, which are a physiologically relevant model of mammary morphogenesis. Bcl-2-associated athanogene 1 (Bag-1) is a multifunctional protein overexpressed in breast cancer...
Autores principales: | Papadakis, E S, Barker, C R, Syed, H, Reeves, T, Schwaiger, S, Stuppner, H, Troppmair, J, Blaydes, J P, Cutress, R I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848832/ https://www.ncbi.nlm.nih.gov/pubmed/27043661 http://dx.doi.org/10.1038/oncsis.2016.10 |
Ejemplares similares
-
A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells
por: Papadakis, Emmanouil, et al.
Publicado: (2016) -
BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
por: Papadakis, E S, et al.
Publicado: (2017) -
Reply to ‘Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses’’
por: Papadakis, E. S., et al.
Publicado: (2018) -
Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1)
por: Greenhough, Joanna, et al.
Publicado: (2016) -
BAG-1 expression and function in human cancer
por: Cutress, R I, et al.
Publicado: (2002)